2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases
US8809536B2 · kind B2 · utility
1Cited by
10References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2014 |
| Grant date | Aug 19, 2014 |
| Priority date | — |
| Expiry date | Feb 27, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D319/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.